MIRIAM GERBER: Open Payments
NPI 1295777993 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 25 payments from 12 companies in 2025. Trend: 2023 $846 · 2024 $1,046 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $122 |
| ABBVIE INC. | 4 | $79 |
| PFIZER INC. | 3 | $72 |
| Lilly USA, LLC | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Seqirus USA Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: Ozempic, MOUNJARO, UBRELVY, VOQUEZNA, QULIPTA, Cologuard Collection Kit, VYNDAMAX, Rybelsus.
Industry payments across TN — which companies pay providers there.
